Lee et al. noted upregulated YAP expression and activation in long-term TKI-induced resistant lung cancer cells and YAP inhibition of TKI-resistant cells restored sensitivity to TKI treatment [81]. The gene discussed is YAP1; the disease is lung carcinoma.